[
  {
    "ts": null,
    "headline": "Markey Researchers Awarded $6.8 Million To Help Others Replicate Kentucky's Lung Cancer Screening Success",
    "summary": "PRINCETON, NJ / ACCESS Newswire / June 6, 2025 /Originally published on University of Kentucky Research News A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) ...",
    "url": "https://finnhub.io/api/news?id=b1743fd230f61fa1bf7b912a710239f2f8316a2fc896492c5c349ed748a7b469",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749217500,
      "headline": "Markey Researchers Awarded $6.8 Million To Help Others Replicate Kentucky's Lung Cancer Screening Success",
      "id": 135079533,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "PRINCETON, NJ / ACCESS Newswire / June 6, 2025 /Originally published on University of Kentucky Research News A groundbreaking lung cancer screening project co-led by the University of Kentucky Markey Cancer Center and the University of Colorado (CU) ...",
      "url": "https://finnhub.io/api/news?id=b1743fd230f61fa1bf7b912a710239f2f8316a2fc896492c5c349ed748a7b469"
    }
  },
  {
    "ts": null,
    "headline": "Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?",
    "summary": "We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands against other stocks that Jim Cramer discusses. In an older segment, a long-time listener asked about Bristol-Myers Squibb Co. (NYSE:BMY) given its dividend and drug […]",
    "url": "https://finnhub.io/api/news?id=a81c4cc3629befdd7fd0dca2fa0be2d63b5d403537b013cfb94ec040610942c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749217290,
      "headline": "Was Jim Cramer Right About Bristol-Myers Squibb Co. (BMY)?",
      "id": 135074200,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands against other stocks that Jim Cramer discusses. In an older segment, a long-time listener asked about Bristol-Myers Squibb Co. (NYSE:BMY) given its dividend and drug […]",
      "url": "https://finnhub.io/api/news?id=a81c4cc3629befdd7fd0dca2fa0be2d63b5d403537b013cfb94ec040610942c5"
    }
  },
  {
    "ts": null,
    "headline": "BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?",
    "summary": "BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure",
    "url": "https://finnhub.io/api/news?id=8bdf08aa6b9dd3b55b16632cb2f779e01b35ade0db84fb1f1e72ed9419c7ad8d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749215760,
      "headline": "BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio?",
      "id": 135079537,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "BMY teams with BioNTech on BNT327, a dual-target cancer therapy, as legacy drugs face mounting generic pressure",
      "url": "https://finnhub.io/api/news?id=8bdf08aa6b9dd3b55b16632cb2f779e01b35ade0db84fb1f1e72ed9419c7ad8d"
    }
  },
  {
    "ts": null,
    "headline": "Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment",
    "summary": "Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I like BMY more than BNTX.",
    "url": "https://finnhub.io/api/news?id=40cf75ca9897f3bf3f3b4d289a9e6137b5c5103261433b512c310964b73f87be",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749193200,
      "headline": "Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment",
      "id": 135070790,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160008492/image_2160008492.jpg?io=getty-c-w1536",
      "related": "BMY",
      "source": "SeekingAlpha",
      "summary": "Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I like BMY more than BNTX.",
      "url": "https://finnhub.io/api/news?id=40cf75ca9897f3bf3f3b4d289a9e6137b5c5103261433b512c310964b73f87be"
    }
  },
  {
    "ts": null,
    "headline": "Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers",
    "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Collegium Pharmaceutical (NASDAQ:COLL) and its peers.",
    "url": "https://finnhub.io/api/news?id=5045267787d54bfcd03689a80f2028b728164e1a5d59f321e14e43229d84981f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749180663,
      "headline": "Branded Pharmaceuticals Stocks Q1 In Review: Collegium Pharmaceutical (NASDAQ:COLL) Vs Peers",
      "id": 135073955,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals industry, including Collegium Pharmaceutical (NASDAQ:COLL) and its peers.",
      "url": "https://finnhub.io/api/news?id=5045267787d54bfcd03689a80f2028b728164e1a5d59f321e14e43229d84981f"
    }
  },
  {
    "ts": null,
    "headline": "Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments",
    "summary": "Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments",
    "url": "https://finnhub.io/api/news?id=77a67bf0c113733b93403a0745a49aae374fe4d781ff3028768ff41898a41519",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749173400,
      "headline": "Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments",
      "id": 135072336,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments",
      "url": "https://finnhub.io/api/news?id=77a67bf0c113733b93403a0745a49aae374fe4d781ff3028768ff41898a41519"
    }
  }
]